VOGT-KOYANAGI-HARADA SYNDROME

VOGT-KOYANAGI-HARADA SYNDROME was reported 112 times

VOGT-KOYANAGI-HARADA SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nucleoside Analog Antiviral [EPC] 38 0.0004
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 14 0.0001
2 CTLA-4-directed Blocking Antibody [EPC] 5 0.0001
3 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
4 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
5 Bile Acid [EPC] 1 0.0000
6 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
7 Polyene Antifungal [EPC] 1 0.0000
8 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
9 Muscle Relaxant [EPC] 1 0.0000
10 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
11 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
12 Prostaglandin Analog [EPC] 1 0.0000
13 Purine Antimetabolite [EPC] 1 0.0000
14 Acetylcholine Release Inhibitor [EPC] 1 0.0000
15 Thiazide Diuretic [EPC] 2 0.0000
16 Corticosteroid [EPC] 11 0.0000
17 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
18 Kinase Inhibitor [EPC] 4 0.0000
19 Insulin Analog [EPC] 3 0.0000
20 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
21 Interferon beta [EPC] 1 0.0000
22 Mood Stabilizer [EPC] 1 0.0000
23 Anti-epileptic Agent [EPC] 1 0.0000
24 Vitamin D [EPC] 1 0.0000
25 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
26 Vitamin B12 [EPC] 1 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
28 Vitamin C [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
31 Atypical Antipsychotic [EPC] 1 0.0000
32 Platelet Aggregation Inhibitor [EPC] 1 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 1 0.0000